<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2022.883568</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Perspective</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mechanical Activation of the &#x3b2;<sub>2</sub>-Adrenergic Receptor by Meningococcus: A Historical and Future Perspective Analysis of How a Bacterial Probe Can Reveal Signalling Pathways in Endothelial Cells, and a Unique Mode of Receptor Activation Involving Its N-Terminal Glycan Chains</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Marullo</surname>
<given-names>Stefano</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/33435"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scott</surname>
<given-names>Mark G. H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/265852"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Enslen</surname>
<given-names>Herv&#xe9;</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/265811"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coureuil</surname>
<given-names>Mathieu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/440927"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Universit&#xe9; de Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104</institution>, <addr-line>Paris</addr-line>, <country>France</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Universit&#xe9; de Paris, Institut-Necker-Enfants-Malades, INSERM U1151, CNRS UMR 8253</institution>, <addr-line>Paris</addr-line>, <country>France</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mari&#xe1;n Castro, University of Santiago de Compostela, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: David Poyner, Aston University, United Kingdom</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Stefano Marullo, <email xlink:href="mailto:stefano.marullo@inserm.fr">stefano.marullo@inserm.fr</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>883568</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Marullo, Scott, Enslen and Coureuil</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Marullo, Scott, Enslen and Coureuil</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>More than 12 years have passed since the seminal observation that meningococcus, a pathogen causing epidemic meningitis in humans, occasionally associated with infectious vasculitis and septic shock, can promote the translocation of &#x3b2;-arrestins to the cell surface beneath bacterial colonies. The cellular receptor used by the pathogen to induce signalling in host cells and allowing it to open endothelial cell junctions and reach meninges was unknown. The involvement of &#x3b2;-arrestins, which are scaffolding proteins regulating G protein coupled receptor signalling and function, incited us to specifically investigate this class of receptors. In this perspective article we will summarize the events leading to the discovery that the &#x3b2;<sub>2</sub>-adrenergic receptor is the receptor that initiates the signalling cascades induced by meningococcus in host cells. This receptor, however, cannot mediate cell infection on its own. It needs to be pre-associated with an &#x201c;early&#x201d; adhesion receptor, CD147, within a hetero-oligomeric complex, stabilized by the cytoskeletal protein &#x3b1;-actinin 4. It then required several years to understand how the pathogen actually activates the signalling receptor. Once bound to the N-terminal glycans of the &#x3b2;<sub>2</sub>-adrenergic receptor, meningococcus provides a mechanical stimulation that induces the biased activation of &#x3b2;-arrestin-mediated signalling pathways. This activating mechanical stimulus can be reproduced in the absence of any pathogen by applying equivalent forces on receptor glycans. Mechanical activation of the &#x3b2;<sub>2</sub>-adrenergic receptor might have a physiological role in signalling events promoted in the context of cell-to-cell interaction.</p>
</abstract>
<kwd-group>
<kwd>meningococcus</kwd>
<kwd>&#x3b2;<sub>2</sub>-adrenergic receptor</kwd>
<kwd>&#x3b2;-arrestin</kwd>
<kwd>N-glycans</kwd>
<kwd>sialic acid</kwd>
<kwd>mechano-transduction</kwd>
<kwd>pilin</kwd>
<kwd>meningitis</kwd>
</kwd-group>
<contract-sponsor id="cn001">Agence Nationale de la Recherche<named-content content-type="fundref-id">10.13039/501100001665</named-content>
</contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="43"/>
<page-count count="7"/>
<word-count count="3238"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<sec id="s1_1">
<title>A Signalling Pathogen With Missing Receptors</title>
<p>Among the multiple pathogens causing infectious diseases in humans, some are more daunting than others. <italic>Neisseria meningitidis (Nm</italic>, also known as meningococcus) belongs to this category. Indeed, this Gram-negative extracellular bacterium can kill a perfectly healthy person in a few hours. Meningococcus behaves in most cases as a commensal non-pathogenic bacterium of the human nasopharynx (<xref ref-type="bibr" rid="B1">1</xref>). However, when it leaves its &#x201c;ecological niche&#x201d; to penetrate into the blood stream it can infect the meninges, the membranes which envelop the brain and spinal cord, causing cerebrospinal meningitis (<xref ref-type="bibr" rid="B2">2</xref>). Moreover, in cases of invasive disease often associated with high bacteraemia (<xref ref-type="bibr" rid="B3">3</xref>), meningococcus disseminates into tissues promoting inflammation and coagulation activation, leading to extensive necrotic <italic>purpura</italic> and sepsis (<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>A key event in meningococcus tissue dissemination is its capacity to interact with host endothelial cells, allowing the rapid colonization of microvessels. The interaction with endothelia largely relies on bacterial filamentous appendages known as type-4 pili (TFP) (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). The chemical inhibition of TFP using drugs that promote their disassembly markedly reduces meningococcus pathogenicity (<xref ref-type="bibr" rid="B7">7</xref>). TFP are made of polymers of protein subunits called pilins, which assemble in long helical structures. PilE, the most abundant pilin within the polymers, can assemble with minor (less abundant) PilV, PilX and ComP pilins (<xref ref-type="bibr" rid="B8">8</xref>). The PilC protein, presumably located at the tip of TFP is involved in pili adhesiveness along with PilV (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Pili are submitted to cycles of extension and retraction that are controlled by 2 ATPases: the PilF ATPase regulates pilin assembly, whereas the PilT ATPase is responsible for TFP disassembly and retraction. The dynamics of TFP elongation and retraction, allows the bacterium to crawl at the surface of endothelial cells and to adapt to microvessel geometry (<xref ref-type="bibr" rid="B11">11</xref>). Recently, TFP retraction was shown to promote the release of TFP-dependent contacts between bacteria facilitating sustained bacteremia (<xref ref-type="bibr" rid="B12">12</xref>). Although not directly measured for <italic>Nm</italic>, it has been established in a study on the close pathogen <italic>N. gonorrhoeae</italic> that TFP retraction can generate proportionally high forces in the nanonewton range (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>The interaction of TFP with both epithelial and endothelial cells promotes the activation of multiple signalling cascades, the visible hallmark of this phenomenon being the bulk accumulation under bacterial colonies of membrane-associated proteins, which form a honeycomb shaped &#x201c;cortical plaque&#x201d; (<xref ref-type="bibr" rid="B14">14</xref>). However, signalling pathways Induced by TFP in endothelial and epithelial cells are different, likely involving different receptors (<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>In endothelial cells, meningococcus induces the accumulation of adhesion molecules, junctional proteins, cytosolic signalling proteins and cytoskeletal proteins, such as ezrin and actin (<xref ref-type="bibr" rid="B16">16</xref>), with two principal pathophysiological consequences. The first is the creation of actin-containing microvilli-like structures perpendicular to the endothelial surface, which protrude between the bacteria of a growing colony and stabilize it under the blood flow (<xref ref-type="bibr" rid="B17">17</xref>). The second is the formation of ectopic intercellular junctional domains at the site of bacteria-host cell interaction and a subsequent depletion of junctional proteins at the cell-cell interface, with opening of the intercellular junctions of the brain-endothelial interface (<xref ref-type="bibr" rid="B18">18</xref>). Early studies identified several signalling mechanism upstream of these cellular changes, including: local activation of Cdc42 and Rho GTPases (<xref ref-type="bibr" rid="B16">16</xref>); Src activation (<xref ref-type="bibr" rid="B19">19</xref>) and subsequent Src-dependent phosphorylation of cortactin, an actin-binding protein that controls actin polymerization; activation of the phosphoinositide-3-kinase (PI3K)/Rac1 pathway (<xref ref-type="bibr" rid="B20">20</xref>). However, the host cell receptor(s) activated by the pathogen upstream of these signalling events remained elusive for many years.</p>
</sec>
</sec>
<sec id="s2">
<title>An Endothelial-Cell Receptor Couple Working Together: One for Signalling, One for Early Adhesion</title>
<p>The accumulation in the cortical plaque of different protein types was consistent with the involvement of one or more scaffolding protein(s) that would be recruited by a putative meningococcus-activated receptor. Two such scaffolding proteins, &#x3b2;-arrestin 1 and 2 (&#x3b2;arr1 and &#x3b2;arr2), which are principally involved in G protein coupled receptor (GPCR) regulation and signalling, appeared as plausible candidates. Previous studies had shown that &#x3b2;arrs were essential for the co-localization of stimulated GPCRs, the actin-binding protein filamin-A and active ERK in membrane ruffles (<xref ref-type="bibr" rid="B21">21</xref>). Moreover, &#x3b2;arrs were shown to participate in the activation of CDC42 (<xref ref-type="bibr" rid="B22">22</xref>), PI3K (<xref ref-type="bibr" rid="B23">23</xref>), and Src (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>The hypothesis of a role for &#x3b2;arrs in <italic>Nm</italic>-induced signalling in host endothelial cells was validated. In monolayers of hCMEC/D3 cells, a human brain endothelial cell line, which stably maintains phenotypic features of BBB in culture (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>), capsulated (pathogenic) piliated meningococci induced the accumulation in cortical plaques of both exogenous &#x3b2;arr2-GFP and endogenous &#x3b2;arr2, together with the proteins that were commonly found under bacterial colonies (<xref ref-type="bibr" rid="B27">27</xref>). Inhibition of &#x3b2;arrs with specific siRNAs inhibited the formation of cortical plaques (visualized by ezrin staining), demonstrating that &#x3b2;arr recruitment to the putative unknown <italic>Nm</italic> receptor was actually an upstream signalling event. Interestingly, siRNA-mediated inhibition of GRK2, a kinase which specifically phosphorylates GPCRs thus providing docking sites for &#x3b2;arrs, prevented &#x3b2;arr translocation under bacterial colonies and cortical plaque formation. This finding represented a strong experimental argument for the involvement of a GPCR in meningococcus signalling. Multiple studies combining loss and gain of function assays demonstrated that the missing signalling receptor in hCMEC/D3 cells was the &#x3b2;<sub>2</sub>-adrenergic receptor (&#x3b2;<sub>2</sub>AR) and provided a comprehensive scenario of the signalling events elicited by <italic>Nm</italic> following its adhesion to human endothelial cells (<xref ref-type="bibr" rid="B27">27</xref>). After binding onto endothelial cells, <italic>Nm</italic> TFP interact with the host cell &#x3b2;<sub>2</sub>AR, leading to its &#x3b2;arr-biased activation, independently of the activation of cognate heterotrimeric G&#x3b1;<sub>s</sub> protein and of its downstream adenylyl cyclase-cAMP pathway. The pilus components PilE and PilV were identified as the specific &#x201c;bacterial ligands&#x201d; involved in &#x3b2;<sub>2</sub>AR activation. Once translocated to &#x3b2;<sub>2</sub>ARs, &#x3b2;arrs drive the 2 major events involved in <italic>Nm</italic> tissue infection: docking and activation of Src, leading to the formation of actin-rich cellular protrusions, which stabilizes bacterial colonies under the blood flow; accumulation under bacterial colonies of proteins, such as VE-cadherin and p120-catenin that are normally located in intracellular junctions, which, once depleted, become permeable to bacteria. However, from the studies above it also emerged that the &#x3b2;<sub>2</sub>AR was not competent for the initial adhesion of the pathogen, corroborated by the fact that &#x3b2;<sub>2</sub>AR-depleted cells still support initial pilus-mediated <italic>Nm</italic> adhesion. These observations were confirming previous reports indicating that TFP-mediated adhesion and signalling are two independent events (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>A differential, quantitative, large-scale analysis of gene expression was conducted in a cell line, which only become permissive for the attachment of piliated capsulated meningococci after phorbol ester 12-O-Tetradecanoylphorbol-13-acetate treatment. This strategy led to the identification of the immunoglobulin superfamily member CD147 (also known as basigin or emmprin) as a brain microvasculature early adhesion receptor for meningococcus (<xref ref-type="bibr" rid="B28">28</xref>). PilE and PilV pilins specifically mediate the interaction of the pathogen with the C-terminal part of the CD147 Ig domain, showing that the same bacterial ligands are involved in the interaction with the signalling and the adhesion receptor. These findings indicated that CD147 and &#x3b2;<sub>2</sub>AR might cooperate to promote firm <italic>Nm</italic> adhesion and subsequent activation of signalling events, and suggested a potential functional connection between these receptors that might pre-exist pathogen infection (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). </p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Mechanical activation of the CD147-&#x3b2;<sub>2</sub>AR heterodimer by meningococcus in endothelial cells. (Left) In endothelial cells CD147 and &#x3b2;<sub>2</sub>AR are pre-assembled into heterodimers stabilized by &#x3b1;-actinin4; the physiological role of these complexes is still unknown. When meningococci penetrate into the blood stream, they interact with these heterodimers <italic>via</italic> the PilE and PilV pilins of their TFP. (Right) The first interaction presumably involves CD147 and is accountable for its &#x201c;early adhesion&#x201d;. Terminal Neu5Ac (sialic acid) of the N-glycan chains present in the proximal IgG domain of CD147 constitutes the binding site of TFP pilins. Other TFP interact <italic>via</italic> PilE and PilV with the terminal Neu5Ac of close &#x3b2;<sub>2</sub>AR N-glycan chains. TFP retraction powered by PilT and forces generated by the blood flow concur to the mechanical activation of the &#x3b2;<sub>2</sub>AR (enlarged inset). The conformational change induced by this activation produces a cascade of signalling events promoted by &#x3b2;arr translocation to GRK2-phosphorylated &#x3b2;<sub>2</sub>AR. Once the &#x201c;stable adhesion&#x201d; of bacterial colonies is achieved meningococci cross the endothelium through intercellular spaces.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-883568-g001.tif"/>
</fig>
<p>The hypothesis of a spatio-temporal coordination between adhesion to CD147 and &#x3b2;<sub>2</sub>AR stimulation by <italic>Nm</italic> TFP was specifically addressed in a subsequent study (<xref ref-type="bibr" rid="B29">29</xref>). CD147 and &#x3b2;2AR were found in pre-existing complexes at the cell surface of endothelial cells independently of bacterial infection. This interaction was stabilized by the cytoskeletal protein actinin-4, which in addition promoted the assembly of highly ordered clusters of receptor complexes in response to meningococcus adhesion. <italic>In vivo</italic>, under blood flow, this multi-molecular assembly process likely provides sufficient binding strength for the initial interaction of TFP with CD147 and then the subsequent rapid activation of the &#x3b2;<sub>2</sub>AR, which ultimately enhances and stabilizes bacterial adhesion.</p>
</sec>
<sec id="s3">
<title>Mechanisms of TFP-Promoted &#x3b2;arr-Biased Activation of the &#x3b2;<sub>2</sub>AR</title>
<p>Initial investigations showed that the &#x3b2;arr-biased activation of the &#x3b2;<sub>2</sub>AR by PilE and PilV components of TFP was allosteric, since a pre-incubated orthosteric antagonist of the receptor did not block it, and likely involved the extracellular N-terminal region of the receptor (<xref ref-type="bibr" rid="B27">27</xref>). Homogeneous time resolved FRET experiments with purified PilE and PilV confirmed their specific direct interaction with this region of the receptor (<xref ref-type="bibr" rid="B30">30</xref>). Intriguingly, the amino-acid composition of &#x3b2;<sub>2</sub>AR N-terminus is conserved in mammals and almost identical for some species to that of human &#x3b2;<sub>2</sub>AR, contrasting with the strict human specificity of meningococcus. Moreover, in a fully reconstituted cellular model of meningococcus signalling, the mouse &#x3b2;<sub>2</sub>AR was activated by the pathogen in cells of human origin, whereas in a symmetrical experiment the human &#x3b2;<sub>2</sub>AR was not stimulated in mouse cells. These findings suggested that host factors, independent of the amino-acid composition, were involved in meningococcus interaction/activation of &#x3b2;<sub>2</sub>AR. The N-terminus of the &#x3b2;<sub>2</sub>AR also contains two asparagine-branched glycan chains, which were then investigated as potential alternative pilin binding sites. In the &#x3b2;<sub>2</sub>AR sequence the asparagine residues from which the glycan chains arise are separated by 9 amino-acid positions. When the two consensus N-glycosylation sites of the &#x3b2;<sub>2</sub>AR were introduced in the sequence of the angiotensin AT1R receptor, which is also expressed in endothelial cells but cannot be stimulated by meningococcus, the resulting chimera became activatable by the pathogen. Interestingly, not only the number but also the distance of the glycan chains in the N-terminus sequence was critical for receptor activation (<xref ref-type="bibr" rid="B30">30</xref>). A panel of lectins (i.e. proteins that exhibit high avidity for glycoprotein- and/or glycolipid-associated carbohydrates) were then pre-incubated with endothelial cells to block the specific glycan(s) involved in the interaction between the &#x3b2;<sub>2</sub>AR and meningococcus. <italic>Nm</italic> signalling was exclusively inhibited by lectins with the capacity of binding to terminal sialic acid (or N-acetyl neuraminic acid). Supporting a role of sialic acid in the interaction of N-terminal glycans with meningococcus, biochemical studies on purified N-terminal &#x3b2;<sub>2</sub>AR domain confirmed that both glycan chains contain sialic acid, whereas the inhibition of sialyl transferases (the enzymes involved in the addition of sialic acid to the glycan chain) prevented <italic>Nm</italic> signalling. These findings were particularly interesting in the context of meningococcus species selectivity. Two principal forms of sialic acids are found in mammals, N-Acetylneuraminic acid (Neu5Ac) and N-Glycolylneuraminic acid (Neu5Gc), which differ by a single oxygen atom (<xref ref-type="bibr" rid="B31">31</xref>). In mammals, Neu5Gc is predominant, whereas humans mainly express Neu5Ac (<xref ref-type="bibr" rid="B32">32</xref>). Neu5Gc is actually synthesised from Neu5Ac by the cytidine monophosphate-N-acetylneuraminic acid hydrolase (CMAH), which is absent in humans, due to a mutation in the <italic>CMAH</italic> gene (<xref ref-type="bibr" rid="B33">33</xref>). The hypothesis that the difference in sialic acids might contribute to the species selectivity was confirmed experimentally. Indeed, the deletion of <italic>CMAH</italic> in mouse endothelial cells restored meningococcal signalling <italic>via</italic> the &#x3b2;<sub>2</sub>AR (<xref ref-type="bibr" rid="B30">30</xref>). The nature of the human N-glycan recognized by <italic>Nm</italic> was further investigated using recombinant CD147 receptors, confirming the role of a complex sialilated N-glycan devoid of fucose residues (<xref ref-type="bibr" rid="B34">34</xref>).</p>
<p>Although it had been established that host-pathogen interactions can involve host cell glycans (<xref ref-type="bibr" rid="B35">35</xref>) and that the signalling properties of some receptors can be modulated by glycosylation (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>), the activation of a GPCR <italic>via</italic> the interaction between a ligand and N-glycan chains had not been reported previously. On the other hand, in addition to their usual role of chemosensors, some GPCRs can be activated by mechanical cues that are transduced by the receptor into intracellular chemical signals (reviewed in (<xref ref-type="bibr" rid="B38">38</xref>)), raising the hypothesis that mechanical forces applied <italic>via</italic> meningococcal TFP to &#x3b2;<sub>2</sub>ARs might similarly produce their activation (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). Indeed, bacteria growing at the cell surface of endothelial cells are permanently submitted to forces exerted by blood flow. In addition, TFP retraction, powered by the PilT ATPase can generate traction forces independently of hemodynamic flow (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Wild type and mutant meningococci deficient in PilT activity [&#x394;<italic>pillT</italic> mutants (<xref ref-type="bibr" rid="B40">40</xref>)] were compared for their capacity to induce signalling in hCMEC/D3 cells. Under basal conditions ezrin recruitment (as a marker of the cortical plaque formation) was significantly impaired under &#x394;<italic>pillT</italic> mutants compared to wild type <italic>Nm</italic>. The application of centrifugal forces on bacteria enhanced ezrin accumulation under both wild type and &#x394;<italic>pillT</italic> colonies, although the effect was significantly larger for wild type bacteria. Maximal signalling was thus obtained with the additive effect of PilT-induced pilus retraction and exogenous forces applied to meningcocci (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>To confirm that pulling forces transmitted <italic>via</italic> N-glycans are sufficient to activate &#x3b2;<sub>2</sub>AR signalling agarose beads coated with lectins that specifically recognize Neu5Ac were used in a reconstituted cell system. After incubation on cell monolayers to allow lectin binding to sialic acid-terminated N-glycan chains of the &#x3b2;<sub>2</sub>AR the beads were submitted to orbital rotation. Whereas under basal conditions, only background accumulation of ezrin (used as activation readout) was observed under the beads, rotation appliance significantly enhanced ezrin accumulation but only when exogenous &#x3b2;<sub>2</sub>AR and &#x3b2;arrs were co-expressed in the cells (<xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion and Perspectives</title>
<p>In addition to their well-established role of chemosensors, which transduce catecholamine stimulation, &#x3b2;<sub>2</sub>AR can also function as mechanosensors for the traction forces applied on their N-terminal glycan chains. The signalling output produced by mechanical stimulation appears biased toward &#x3b2;arr-dependent pathways, since the receptor cognate Gs protein is not activated. However, in the presence of particular ligands, GPGRs can switch their coupling to a non-cognate G protein, likely because these ligands stabilize a unique receptor conformation that is competent for this unusual coupling. For example, carvedilol, an inverse-agonist of the classically Gs-coupled &#x3b2;<sub>1</sub>-adrenergic receptor (&#x3b2;<sub>1</sub>AR), was reported to promote its coupling to the inhibitory G protein Gi, in addition to the recruitment of &#x3b2;arrs (<xref ref-type="bibr" rid="B41">41</xref>). Moreover, this study demonstrated the existence of interplay between Gi and &#x3b2;arrs in the activation of the ERK1/2 MAP kinase pathway. Cell pre-incubation with pertussis toxin (PTX), which prevents Gi from interacting with GPCRs, partially inhibited meningococcus-induced signalling (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>), suggesting that the mechanical traction forces on glycan chains similarly stabilize a unique &#x3b2;<sub>2</sub>AR active conformation capable of synergistic Gi coupling and activation of &#x3b2;arr signalling. This or a close conformation is likely also obtained by applying traction forces <italic>via</italic> beads that are coated with lectins specific for the exposed sialic acid of receptor glycan chains. Finally, the effect of PTX is consistent with previous studies indicating that signalling events attributed to &#x3b2;arrs might actually require some G protein contribution (<xref ref-type="bibr" rid="B42">42</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Pertussis toxin inhibits meningococcus-induced signalling. Endothelial hCMEC/D3 cells were infected with wild type <italic>N. meningitidis</italic> and submitted to centrifugal forces with or without pertussis toxin pre-incubation (PTX - 20ng/ml). Cells were then processed for the analysis of ezrin recruitment under bacterial colonies. Top panel: the intensity of ezrin recruitment was quantified for each individual colony and expressed as arbitrary units per pixel under colonies (as in <xref ref-type="bibr" rid="B30">30</xref>). Each dot represents one colony. Median values (in red) with interquartile range are shown. A Mann-Whitney test was used to determine significant differences between median values. p=0.0002. Bottom panel: Representative immunofluorescence images. HCMEC/D3 cell nuclei and bacterial DNA (small, grouped dots) were labelled with DAPI (red); anti-ezrin antibodies stained ezrin (green). Arrows pointed at ezrin-enriched villi. Bar: 10&#xb5;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-883568-g002.tif"/>
</fig>
<p>Although there is no evidence at the moment that, in addition to the pathophysiological role in meningococcal infection, this mode of activation of the &#x3b2;<sub>2</sub>AR is involved in physiological processes, this hypothesis merits further investigations. Indeed, many cell types express integral lectins as structural components of their plasma membrane. Among them, I-type lectins are glycan-binding proteins in which the binding domain is homologous to immunoglobulin superfamily proteins. The Siglec family is a subgroup of I-type lectins, which all recognizes terminal sialic acids with specificity for adjacent carbohydrates within the glycan chain. Most Siglecs have one or more tyrosine-based signalling motifs in their cytoplasmic tails, or associate with membrane adaptor proteins containing cytosolic tyrosine motifs. Following their tyrosine phosphorylation by Src family kinases, they recruit and activate SH2-domain-containing effectors (<xref ref-type="bibr" rid="B43">43</xref>). Siglecs are expressed by blood cells, microglia, osteoclasts, myelin forming cells, and placental trophoblasts. Macrophages, adhere to and roll over endothelial cells before stopping under blood flow and penetrate into tissues. They express at the cell surface Siglec-1 (<xref ref-type="bibr" rid="B35">35</xref>), which displays the same glycan specificity as Mal-I, one of the lectins that block meningococcal signalling. In this context Siglec-1 might bind to the &#x3b2;<sub>2</sub>AR and induce signalling pathways contributing to macrophage diapedesis. Also, signalling promoted by cell-to-cell interactions are essential during development, during which sialic-acids are known to play a major role, as shown by early embryonic lethality in case of disruption of sialic acid synthesis (<xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>More generally, GPCRs are almost ubiquitous and 80% of them display one or more N-glycan chains, which might similarly be involved in the interaction with surrounding cells through lectins. Although, it is difficult at the moment to evaluate how many GPCRs could actually be activated <italic>via</italic> a traction applied on their N-glycans, &#x3b2;<sub>2</sub>AR might not be a unique example, since the angiotensin AT1R engineered to express a second glycan chain in its N-terminus can be activated by meningococcus.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author Contributions</title>
<p>SM wrote the first version of the manuscript, which was reviewed and corrected by the co-authors. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>This article was supported by ANR-14-IFEC-0006-01, ANR-15-CE15-0002 and ANR-19-CE14-0045 grants. SM and MC are also supported by the INSERM, the CNRS, and the Universit&#xe9; de Paris.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephens</surname> <given-names>DS</given-names>
</name>
</person-group>. <article-title>Biology and Pathogenesis of the Evolutionarily Successful, Obligate Human Bacterium Neisseria Meningitidis</article-title>. <source>Vaccine</source> (<year>2009</year>) <volume>27</volume>:<page-range>B71&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.04.070</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coureuil</surname> <given-names>M</given-names>
</name>
<name>
<surname>Join-Lambert</surname> <given-names>O</given-names>
</name>
<name>
<surname>Lecuyer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bourdoulous</surname> <given-names>S</given-names>
</name>
<name>
<surname>Marullo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Mechanism of Meningeal Invasion by Neisseria Meningitidis</article-title>. <source>Virulence</source> (<year>2012</year>) <volume>3</volume>:<page-range>164&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.4161/viru.18639</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darton</surname> <given-names>T</given-names>
</name>
<name>
<surname>Guiver</surname> <given-names>M</given-names>
</name>
<name>
<surname>Naylor</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jack</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Kaczmarski</surname> <given-names>EB</given-names>
</name>
<name>
<surname>Borrow</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Severity of Meningococcal Disease Associated With Genomic Bacterial Load</article-title>. <source>Clin Infect Dis</source> (<year>2009</year>) <volume>48</volume>:<page-range>587&#x2013;94</page-range>. doi: <pub-id pub-id-type="doi">10.1086/596707</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coureuil</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bourdoulous</surname> <given-names>S</given-names>
</name>
<name>
<surname>Marullo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Invasive Meningococcal Disease: A Disease of the Endothelial Cells</article-title>. <source>Trends Mol Med</source> (<year>2014</year>) <volume>20</volume>:<page-range>571&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.molmed.2014.08.002</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dos Santos Souza</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ma&#xef;ssa</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ziveri</surname> <given-names>J</given-names>
</name>
<name>
<surname>Morand</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Coureuil</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Meningococcal Disease: A Paradigm of Type-IV Pilus Dependent Pathogenesis</article-title>. <source>Cell Microbiol</source> (<year>2020</year>) <volume>22</volume>:<elocation-id>e13185</elocation-id>. doi: <pub-id pub-id-type="doi">10.1111/cmi.13185</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Virji</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kayhty</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ferguson</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Alexandrescu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Heckels</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Moxon</surname> <given-names>ER</given-names>
</name>
</person-group>. <article-title>The Role of Pili in the Interactions of Pathogenic Neisseria With Cultured Human Endothelial Cells</article-title>. <source>Mol Microbiol</source> (<year>1991</year>) <volume>5</volume>:<page-range>1831&#x2013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.1991.tb00807.x</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denis</surname> <given-names>K</given-names>
</name>
<name>
<surname>Le Bris</surname> <given-names>M</given-names>
</name>
<name>
<surname>Le Guennec</surname> <given-names>L</given-names>
</name>
<name>
<surname>Barnier</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Faure</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gouge</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Targeting Type IV Pili as an Antivirulence Strategy Against Invasive Meningococcal Disease</article-title>. <source>Nat Microbiol</source> (<year>2019</year>) <volume>4</volume>:<page-range>972&#x2013;84</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41564-019-0395-8</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Craig</surname> <given-names>L</given-names>
</name>
<name>
<surname>Pique</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Tainer</surname> <given-names>JE</given-names>
</name>
</person-group>. <article-title>Type IV Pilus Structure and Bacterial Pathogenicity</article-title>. <source>Nat Rev Microbiol</source> (<year>2004</year>) <volume>2</volume>:<page-range>363&#x2013;78</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro885</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnier</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kolappan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bouzinba-S&#xe9;gard</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gesbert</surname> <given-names>G</given-names>
</name>
<name>
<surname>Jamet</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>The Minor Pilin PilV Provides a Conserved Adhesion Site Throughout the Antigenically Variable Meningococcal Type IV Pilus</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2021</year>) <volume>118</volume>:<elocation-id>e2109364118</elocation-id>. doi: <pub-id pub-id-type="doi">10.1073/pnas.2109364118</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudel</surname> <given-names>T</given-names>
</name>
<name>
<surname>Scheuerpflug</surname> <given-names>I</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>TF</given-names>
</name>
</person-group>. <article-title>Neisseria PilC Protein Identified as Type-4 Pilus Tip-Located Adhesin</article-title>. <source>Nature</source> (<year>1995</year>) <volume>373</volume>:<page-range>357&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/373357a0</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonazzi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lo Schiavo</surname> <given-names>V</given-names>
</name>
<name>
<surname>Machata</surname> <given-names>S</given-names>
</name>
<name>
<surname>Djafer-Cherif</surname> <given-names>I</given-names>
</name>
<name>
<surname>Nivoit</surname> <given-names>P</given-names>
</name>
<name>
<surname>Manriquez</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Intermittent Pili-Mediated Forces Fluidize Neisseria Meningitidis Aggregates Promoting Vascular Colonization</article-title>. <source>Cell</source> (<year>2018</year>) <volume>174</volume>:<fpage>143</fpage>&#x2013;<lpage>55.e116</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2018.04.010</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnier</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Euphrasie</surname> <given-names>D</given-names>
</name>
<name>
<surname>Join-Lambert</surname> <given-names>O</given-names>
</name>
<name>
<surname>Audry</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schonherr-Hellec</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schmitt</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Type IV Pilus Retraction Enables Sustained Bacteremia and Plays a Key Role in the Outcome of Meningococcal Sepsis in a Humanized Mouse Model</article-title>. <source>PloS Pathog</source> (<year>2021</year>) <volume>17</volume>:<elocation-id>e1009299</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1009299</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biais</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ladoux</surname> <given-names>B</given-names>
</name>
<name>
<surname>Higashi</surname> <given-names>D</given-names>
</name>
<name>
<surname>So</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sheetz</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Cooperative Retraction of Bundled Type IV Pili Enables Nanonewton Force Generation</article-title>. <source>PloS Biol</source> (<year>2008</year>) <volume>6</volume>:<elocation-id>e87</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pbio.0060087</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merz</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Enns</surname> <given-names>CA</given-names>
</name>
<name>
<surname>So</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Type IV Pili of Pathogenic Neisseriae Elicit Cortical Plaque Formation in Epithelial Cells</article-title>. <source>Mol Microbiol</source> (<year>1999</year>) <volume>32</volume>:<page-range>1316&#x2013;32</page-range>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2958.1999.01459.x</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xe9;cuyer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
<name>
<surname>Coureuil</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Two Strikingly Different Signaling Pathways are Induced by Meningococcal Type IV Pili on Endothelial and Epithelial Cells</article-title>. <source>Infect Immun</source> (<year>2012</year>) <volume>80</volume>:<page-range>175&#x2013;86</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.05837-11</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eugene</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>I</given-names>
</name>
<name>
<surname>Pujol</surname> <given-names>C</given-names>
</name>
<name>
<surname>Couraud</surname> <given-names>PO</given-names>
</name>
<name>
<surname>Bourdoulous</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Microvilli-Like Structures are Associated With the Internalization of Virulent Capsulated Neisseria Meningitidis Into Vascular Endothelial Cells</article-title>. <source>J Cell Sci</source> (<year>2002</year>) <volume>115</volume>:<page-range>1231&#x2013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1242/jcs.115.6.1231</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikaty</surname> <given-names>G</given-names>
</name>
<name>
<surname>Soyer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mairey</surname> <given-names>E</given-names>
</name>
<name>
<surname>Henry</surname> <given-names>N</given-names>
</name>
<name>
<surname>Dyer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Forest</surname> <given-names>KT</given-names>
</name>
<etal/>
</person-group>. <article-title>Extracellular Bacterial Pathogen Induces Host Cell Surface Reorganization to Resist Shear Stress</article-title>. <source>PloS Pathog</source> (<year>2009</year>) <volume>5</volume>:<elocation-id>e1000314</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1000314</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coureuil</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mikaty</surname> <given-names>G</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>F</given-names>
</name>
<name>
<surname>Lecuyer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bernard</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bourdoulous</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Meningococcal Type IV Pili Recruit the Polarity Complex to Cross the Brain Endothelium</article-title>. <source>Science</source> (<year>2009</year>) <volume>325</volume>:<page-range>83&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1173196</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname> <given-names>I</given-names>
</name>
<name>
<surname>Eugene</surname> <given-names>E</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
<name>
<surname>Couraud</surname> <given-names>PO</given-names>
</name>
<name>
<surname>Bourdoulous</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Activation of ErbB2 Receptor Tyrosine Kinase Supports Invasion of Endothelial Cells by Neisseria Meningitidis</article-title>. <source>J Cell Biol</source> (<year>2001</year>) <volume>155</volume>:<page-range>133&#x2013;43</page-range>. doi: <pub-id pub-id-type="doi">10.1083/jcb.200106148</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambotin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>I</given-names>
</name>
<name>
<surname>Laran-Chich</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
<name>
<surname>Couraud</surname> <given-names>PO</given-names>
</name>
<name>
<surname>Bourdoulous</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Invasion of Endothelial Cells by Neisseria Meningitidis Requires Cortactin Recruitment by a Phosphoinositide-3-Kinase/Rac1 Signalling Pathway Triggered by the Lipo-Oligosaccharide</article-title>. <source>J Cell Sci</source> (<year>2005</year>) <volume>118</volume>:<page-range>3805&#x2013;16</page-range>. doi: <pub-id pub-id-type="doi">10.1242/jcs.02514</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott</surname> <given-names>MGH</given-names>
</name>
<name>
<surname>Pierotti</surname> <given-names>V</given-names>
</name>
<name>
<surname>Storez</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lindberg</surname> <given-names>E</given-names>
</name>
<name>
<surname>Thuret</surname> <given-names>A</given-names>
</name>
<name>
<surname>Muntaner</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Cooperative Regulation of ERK Activation and Cell Shape Change by Filamin A and &#xdf;-Arrestins</article-title>. <source>Mol Cell Biol</source> (<year>2006</year>) <volume>26</volume>:<page-range>3432&#x2013;45</page-range>. doi: <pub-id pub-id-type="doi">10.1128/MCB.26.9.3432-3445.2006</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mythreye</surname> <given-names>K</given-names>
</name>
<name>
<surname>Blobe</surname> <given-names>GC</given-names>
</name>
</person-group>. <article-title>The Type III TGF-Beta Receptor Regulates Epithelial and Cancer Cell Migration Through Beta-Arrestin2-Mediated Activation of Cdc42</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2009</year>) <volume>106</volume>:<page-range>8221&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0812879106</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Povsic</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Kohout</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Lefkowitz</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Beta-Arrestin1 Mediates Insulin-Like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-Apoptosis</article-title>. <source>J Biol Chem</source> (<year>2003</year>) <volume>278</volume>:<page-range>51334&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M309968200</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luttrell</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Ferguson</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Daaka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Maudsley</surname> <given-names>S</given-names>
</name>
<name>
<surname>Della Rocca</surname> <given-names>GJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Beta-Arrestin-Dependent Formation of Beta2 Adrenergic Receptor-Src Protein Kinase Complexes</article-title>. <source>Science</source> (<year>1999</year>) <volume>283</volume>:<page-range>655&#x2013;61</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.283.5402.655</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poller</surname> <given-names>B</given-names>
</name>
<name>
<surname>Gutmann</surname> <given-names>H</given-names>
</name>
<name>
<surname>Krahenbuhl</surname> <given-names>S</given-names>
</name>
<name>
<surname>Weksler</surname> <given-names>B</given-names>
</name>
<name>
<surname>Romero</surname> <given-names>I</given-names>
</name>
<name>
<surname>Couraud</surname> <given-names>PO</given-names>
</name>
<etal/>
</person-group>. <article-title>The Human Brain Endothelial Cell Line hCMEC/D3 as a Human Blood-Brain Barrier Model for Drug Transport Studies</article-title>. <source>J Neurochem</source> (<year>2008</year>) <volume>107</volume>:<page-range>1358&#x2013;68</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05730.x</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weksler</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Subileau</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Perriere</surname> <given-names>N</given-names>
</name>
<name>
<surname>Charneau</surname> <given-names>P</given-names>
</name>
<name>
<surname>Holloway</surname> <given-names>K</given-names>
</name>
<name>
<surname>Leveque</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Blood-Brain Barrier-Specific Properties of a Human Adult Brain Endothelial Cell Line</article-title>. <source>FASEB J</source> (<year>2005</year>) <volume>19</volume>:<page-range>1872&#x2013;4</page-range>. doi: <pub-id pub-id-type="doi">10.1096/fj.04-3458fje</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coureuil</surname> <given-names>M</given-names>
</name>
<name>
<surname>L&#xe9;cuyer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>MGH</given-names>
</name>
<name>
<surname>Boularan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Enslen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Soyer</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Meningococcus Hijack a &#xdf;2-Adrenoceptor-&#xdf;-Arrestin Pathway to Cross Brain Microvasculature Endothelium</article-title>. <source>Cell</source> (<year>2010</year>) <volume>143</volume>:<page-range>1149&#x2013;60</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2010.11.035</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernard</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Simpson</surname> <given-names>N</given-names>
</name>
<name>
<surname>Join-Lambert</surname> <given-names>O</given-names>
</name>
<name>
<surname>Federici</surname> <given-names>C</given-names>
</name>
<name>
<surname>Laran-Chich</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Maissa</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Pathogenic Neisseria Meningitidis Utilizes CD147 for Vascular Colonization</article-title>. <source>Nat Med</source> (<year>2014</year>) <volume>20</volume>:<page-range>725&#x2013;31</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nm.3563</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma&#xef;ssa</surname> <given-names>N</given-names>
</name>
<name>
<surname>Covarelli</surname> <given-names>V</given-names>
</name>
<name>
<surname>Janel</surname> <given-names>S</given-names>
</name>
<name>
<surname>Durel</surname> <given-names>B</given-names>
</name>
<name>
<surname>Simpson</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bernard</surname> <given-names>SC</given-names>
</name>
<etal/>
</person-group>. <article-title>Strength of Neisseria Meningitidis Binding to Endothelial Cells Requires Highly-Ordered CD147/&#x3b2;2-Adrenoceptor Clusters Assembled by Alpha-Actinin-4</article-title>. <source>Nat Commun</source> (<year>2017</year>) <volume>8</volume>:<fpage>15764</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms15764</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Virion</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Doly</surname> <given-names>S</given-names>
</name>
<name>
<surname>Saha</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lambert</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bied</surname> <given-names>C</given-names>
</name>
<name>
<surname>Duke</surname> <given-names>RM</given-names>
</name>
<etal/>
</person-group>. <article-title>Sialic Acid-Mediated Mechanical Activation of &#x3b2;2 Adrenergic Receptors by Bacterial Pilins</article-title>. <source>Nat Commun</source> (<year>2019</year>) <volume>10</volume>:<fpage>4752</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-019-12685-6</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varki</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Loss of N-Glycolylneuraminic Acid in Humans: Mechanisms, Consequences, and Implications for Hominid Evolution</article-title>. <source>Am J Phys Anthropol</source> (<year>2001</year>) <volume>33</volume>:<fpage>54</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ajpa.10018</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varki</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Glycan-Based Interactions Involving Vertebrate Sialic-Acid-Recognizing Proteins</article-title>. <source>Nature</source> (<year>2007</year>) <volume>446</volume>:<page-range>1023&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature05816</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawano</surname> <given-names>T</given-names>
</name>
<name>
<surname>Koyama</surname> <given-names>S</given-names>
</name>
<name>
<surname>Takematsu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kozutsumi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kawasaki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kawashima</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular Cloning of Cytidine Monophospho-N-Acetylneuraminic Acid Hydroxylase. Regulation of Species- and Tissue-Specific Expression of N-Glycolylneuraminic Acid</article-title>. <source>J Biol Chem</source> (<year>1995</year>) <volume>270</volume>:<page-range>16458&#x2013;63</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.270.27.16458</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Guennec</surname> <given-names>L</given-names>
</name>
<name>
<surname>Virion</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Bouzinba-S&#xe9;gard</surname> <given-names>H</given-names>
</name>
<name>
<surname>Robbe-Masselot</surname> <given-names>C</given-names>
</name>
<name>
<surname>L&#xe9;onard</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Receptor Recognition by Meningococcal Type IV Pili Relies on a Specific Complex N-Glycan</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2020</year>) <volume>117</volume>:<page-range>2606&#x2013;12</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1919567117</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varki</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Biological Roles of Glycans</article-title>. <source>Glycobiology</source> (<year>2017</year>) <volume>27</volume>:<fpage>3</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1093/glycob/cww086</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luca</surname> <given-names>VC</given-names>
</name>
<name>
<surname>Jude</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Pierce</surname> <given-names>NW</given-names>
</name>
<name>
<surname>Nachury</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Garcia</surname> <given-names>KC</given-names>
</name>
</person-group>. <article-title>Structural Basis for Notch1 Engagement Ofvdelta-Like 4</article-title>. <source>Science</source> (<year>2015</year>) <volume>347</volume>:<page-range>847&#x2013;53</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1261093</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Nakayama</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hikita</surname> <given-names>T</given-names>
</name>
<name>
<surname>Handa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hakomori</surname> <given-names>SI</given-names>
</name>
</person-group>. <article-title>Epidermal Growth Factor Receptor Tyrosine Kinase is Modulated by GM3 Interaction With N-Linked GlcNAc Termini of the Receptor</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2006</year>) <volume>103</volume>:<page-range>18987&#x2013;91</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0609281103</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marullo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Doly</surname> <given-names>S</given-names>
</name>
<name>
<surname>Saha</surname> <given-names>K</given-names>
</name>
<name>
<surname>Enslen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>MGH</given-names>
</name>
<name>
<surname>Coureuil</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Mechanical GPCR Activation by Traction Forces Exerted on Receptor N-Glycans</article-title>. <source>ACS Pharmacol Trans science</source> (<year>2020</year>) <volume>3</volume>:<page-range>171&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1021/acsptsci.9b00106</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merz</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>So</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sheetz</surname> <given-names>MP</given-names>
</name>
</person-group>. <article-title>Pilus Retraction Powers Bacterial Twitching Motility</article-title>. <source>Nature</source> (<year>2000</year>) <volume>407</volume>:<fpage>98</fpage>&#x2013;<lpage>102</lpage>. doi: <pub-id pub-id-type="doi">10.1038/35024105</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pujol</surname> <given-names>C</given-names>
</name>
<name>
<surname>Eugene</surname> <given-names>E</given-names>
</name>
<name>
<surname>Marceau</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nassif</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>The Meningococcal PilT Protein is Required for Induction of Intimate Attachment to Epithelial Cells Following Pilus-Mediated Adhesion</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>1999</year>) <volume>96</volume>:<page-range>4017&#x2013;22</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.96.7.4017</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hanada</surname> <given-names>K</given-names>
</name>
<name>
<surname>Staus</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Makara</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Dahal</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Galphai is Required for Carvedilol-Induced Beta1 Adrenergic Receptor Beta-Arrestin Biased Signaling</article-title>. <source>Nat Commun</source> (<year>2017</year>) <volume>8</volume>:<fpage>1706</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-017-01855-z</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grundmann</surname> <given-names>M</given-names>
</name>
<name>
<surname>Merten</surname> <given-names>N</given-names>
</name>
<name>
<surname>Malfacini</surname> <given-names>D</given-names>
</name>
<name>
<surname>Inoue</surname> <given-names>A</given-names>
</name>
<name>
<surname>Preis</surname> <given-names>P</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Lack of Beta-Arrestin Signaling in the Absence of Active G Proteins</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>:<fpage>341</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-017-02661-3</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Varki</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schnaar</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Schauer</surname> <given-names>R</given-names>
</name>
</person-group>. <source>Sialic Acids and Other Nonulosonic Acids. In Essentials of Glycobiology</source>. <edition>3rd ed</edition>. <person-group person-group-type="editor">
<name>
<surname>C.R. Varki</surname> <given-names>A</given-names>
</name>
<name>
<surname>Esko</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Stanley</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hart</surname> <given-names>GW</given-names>
</name>
<name>
<surname>Aebi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Darvill</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Kinoshita</surname> <given-names>T</given-names>
</name>
<name>
<surname>Packer</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Prestegard</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Schnaar</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Seeberger</surname> <given-names>PH</given-names>
</name>
</person-group>, editors. <publisher-loc>Cold Spring Harbor (NY</publisher-loc>: <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name> (<year>2017</year>) p. <page-range>2015&#x2013;7</page-range>.</citation>
</ref>
</ref-list>
</back>
</article>